Gender, Race, and Survival: A Study in Non-Small-Cell Lung Cancer Brain Metastases Patients Utilizing the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 4, 2009, Pages 1141-1147

  Videtic, Gregory M M ^a   Reddy, Chandana A ^a   Chao, Samuel T ^a   Rice, Thomas W ^a   Adelstein, David J ^a   Barnett, Gene H ^a   Mekhail, Tarek M ^a   Vogelbaum, Michael A ^a   Suh, John H ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Brain metastases; Gender; Non small cell lung cancer; Race ethnicity; RPA classification

Indexed keywords

BRAIN METASTASIS; BRAIN TUMORS; CLASS II; MEDIAN SURVIVAL; MULTIVARIABLE ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; RADIATION THERAPY ONCOLOGY GROUPS; RECURSIVE PARTITIONING ANALYSIS; RELATIVE RISKS;

BRAIN; FLUORINE CONTAINING POLYMERS; ONCOLOGY; RADIOTHERAPY; RECURSIVE FUNCTIONS; REGRESSION ANALYSIS; RISK ANALYSIS; TUMORS;

PATHOLOGY;

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; FEMALE; GENDER; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RACE; RADIATION DOSE FRACTIONATION; RECURSIVE PARTITIONING ANALYSIS CLASSIFICATION; RETROSPECTIVE STUDY; SURVIVAL TIME; BRAIN TUMOR; ETHNOLOGY; LUNG TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEGRO; SEX DIFFERENCE; SKULL IRRADIATION; STATISTICAL MODEL; STATISTICS; SURVIVAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CRANIAL IRRADIATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LINEAR MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 70449711694     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.022     Document Type: Article

References (41)

1. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 (1997) 745-751
2. Gaspar L.E., Scott C., Murray K., et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47 (2000) 1001-1006
3. Agboola O., Benoit B., Cross P., et al. Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 42 (1998) 155-159
4. Sanghavi S.N., Miranpuri S.S., Chappell R., et al. Radiosurgery for patients with brain metastases: A multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 51 (2001) 426-434
5. Cannady S.B., Cavanaugh K.A., Lee S.Y., et al. Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: A retrospective study. Int J Radiat Oncol Biol Phys 58 (2004) 253-258
6. Videtic G.M., Adelstein D.J., Mekhail T.M., et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys 67 (2007) 240-243
7. Ho C., Murray N., Laskin J., et al. Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America. Lung Cancer 49 (2005) 225-231
8. Patel J.D. Lung cancer in women. J Clin Oncol 23 (2005) 3212-3218
9. Blackstock A.W., Herndon II J.E., Paskett E.D., et al. Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: Report from the Cancer and Leukemia Group B. J Clin Oncol 24 (2006) 407-412
10. Chatkin J.M., Abreu C.M., Fritscher C.C., et al. Is there a gender difference in non-small cell lung cancer survival?. Gend Med 1 (2004) 41-47
11. Patel J.D., Bach P.B., and Kris M.G. Lung cancer in US women: A contemporary epidemic. JAMA 291 (2004) 1763-1768
12. Baldini E.H., and Strauss G.M. Women and lung cancer: Waiting to exhale. Chest 112 4 Suppl (1997) 229S-234S
13. Radzikowska E., Glaz P., and Roszkowski K. Lung cancer in women: Age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 13 (2002) 1087-1093
14. Albain K.S., Crowley J.J., LeBlanc M., et al. Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience. J Clin Oncol 9 (1991) 1618-1626
15. Johnson B.E., Steinberg S.M., Phelps R., et al. Female patients with small cell lung cancer live longer than male patients. Am J Med 85 (1988) 194-196
16. Albain K.S., Crowley J.J., LeBlanc M., et al. Determinants of improved outcome in small-cell lung cancer: An analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 8 (1990) 1563-1574
17. Wolf M., Holle R., Hans K., et al. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): The role of sex as a predictor for survival. Br J Cancer 63 (1991) 986-992
18. de Wet M., Falkson G., and Rapoport B.L. Small cell lung cancer: Analysis of factors influencing the response to treatment and survival. Oncology 51 (1994) 523-534
19. Christodolou C., Pavlidis N., Samantas E., et al. Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study. Anticancer Res 22 (2002) 3749-3757
20. Spiegelman D., Maurer L.H., Ware J.H., et al. Prognostic factors in small-cell carcinoma of the lung: An analysis of 1,521 patients. J Clin Oncol 7 (1989) 344-354
21. Videtic G.M.M., Truong P.T., Ash R.B., et al. Does sex influence the impact that smoking, treatment interruption and impaired pulmonary function have on outcomes in limited stage small cell lung cancer treatment?. Can Resp J 12 (2005) 245-250
22. Lagerwaard F.J., Levendag P.C., Nowak P.J., et al. Identification of prognostic factors in patients with brain metastases: A review of 1292 patients. Int J Radiat Oncol Biol Phys 43 (1999) 795-803
23. Paesmans M., Sculier J.P., Libert P., et al. Prognostic factors for survival in advanced non-small-cell lung cancer: Univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. J Clin Oncol 13 (1995) 1221-1230
24. Jacot W., Quantin X., Boher J.M., et al. Brain metastases at the time of presentation of non-small cell lung cancer: A multi-centric AERIO analysis of prognostic factors. Br J Cancer 84 (2001) 903-909
25. Wronski M., Arbit E., Burt M., et al. Survival after surgical treatment of brain metastases from lung cancer: A follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg 83 (1995) 605-616
26. Getman V., Devyatko E., Dunkler D., et al. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment. Eur J Cardiothorac Surg 25 (2004) 1107-1113
27. Robin E., Bitran J.D., Golomb H.M., et al. Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer 49 (1982) 1916-1919
28. Novello S., and Vavalà T. Lung cancer and women. Future Oncol 4 (2008) 705-716
29. Fotsis T., Zhang Y., Pepper M.S., et al. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368 (1994) 237-239
30. Canver C.C., Memoli V.A., Vanderveer P.L., et al. Sex hormone receptors in non-small-cell lung cancer in human beings. J Thorac Cardiovasc Surg 108 (1994) 153-157
31. D'Amico T.A., Aloia T.A., Moore M.B., et al. Molecular biologic substaging of stage I lung cancer according to gender and histology. Ann Thorac Surg 69 (2000) 882-886
32. Vallböhmer D., Brabender J., Yang D.Y., et al. Sex differences in the predictive power of the molecular prognostic factor HER2/neu in patients with non-small-cell lung cancer. Clin Lung Cancer 7 (2006) 332-337
33. Metro G., Finocchiaro G., Toschi L., et al. Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC). Rev Recent Clin Trials 1 (2006) 1-13
34. Dannenberg K., Brabender J., Schneider S., et al. Gender differences in the predictive power of prognostic factors in NSCLC (Abstr.). Proc Am Soc Clin Oncol 22 (2004) 619s
35. Hastings R.H., Laux A.M.P., Casillas A., et al. Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients. Clin Cancer Res 12 (2006) 499-506
36. Gadgeel S.M., and Kalemkerian G.P. Racial differences in lung cancer. Cancer Metastasis Rev 22 (2003) 39-46
37. Stat bite. Age-adjusted lung cancer mortality rates, 1990-2000. J Natl Cancer Inst 19 (2004) 731
38. Gadgeel S.M., Severson R.K., Kau Y., et al. Impact of race in lung cancer: Analysis of temporal trends from a surveillance, epidemiology, and end results database. Chest 120 (2001) 55-63
39. Tammemagi C.M., Neslund-Dudas C., Simoff M., et al. Lung carcinoma symptoms-An independent predictor of survival and an important mediator of African-American disparity in survival. Cancer 101 (2004) 1655-1663
40. Fan K.J., and Kovi J. Metastatic brain tumors in two predominantly black hospitals: A statistical analysis. J Natl Med Assoc 71 (1979) 671-672
41. Kepka L., Cieslak E., Bujko K., et al. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: The RTOG RPA intra-classes analysis. Acta Oncol 44 (2005) 389-398